Vacuum thrombectomy for pulmonary embolism in cancer patients
Part of Cancer clinical trials.
This trial tests a computer-assisted vacuum device to remove blood clots from the lungs of people with cancer. It aims to see if this procedure is safe and improves quality of life for those with intermediate-risk pulmonary embolism.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer (new or past).
- You have a blood clot in a major lung artery confirmed by CT scan.
- Your blood clot is considered intermediate risk (not causing shock).
- You are at least 18 years old.
- You are generally able to care for yourself (ECOG score 0-3).
- Your blood counts and organ function are adequate for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the Vibrato Aspiration System, a device that suctions blood clots from the lungs in people with a recent pulmonary embolism (PE). It aims to see if the procedure is safe and works well for removing clots.
This trial studies how to quickly and safely rule out blood clots in the lungs of cancer patients who come to the emergency room. It aims to help doctors make faster decisions and avoid unnecessary treatments for people with cancer.
This study tests whether people with active cancer and a new blood clot in the lung can be safely treated at home instead of in the hospital. If you have cancer and a blood clot that is not causing severe symptoms, you may be able to join this trial.
This study tests a new device (AlphaVac) that removes blood clots from the lungs using a thin tube inserted through a vein. It may be an option for people with acute pulmonary embolism who have signs of heart strain or low blood pressure.
This trial tests a procedure that uses ultrasound to guide a catheter that delivers clot-dissolving medicine directly to a blood clot in the lungs. It is for people who have a pulmonary embolism that causes some heart strain but who are not in shock.
This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.